Intriguingly, expression of PRMT1 in relapsed/refractory patients is significantly higher than that of in newly diagnostic patient, indicating that PRMT1 might be a vulnerability for relapsed/refractory MM. The gene discussed is PRMT1; the disease is Miyoshi myopathy.